These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5223180)

  • 1. Abnormal carbohydrate metabolism in patients with malignant blood dyscrasias.
    Lisker SA; Brody JI; Beizer LH
    Am J Med Sci; 1966 Sep; 252(3):282-8. PubMed ID: 5223180
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-thromboglobulin content in megakaryocytes of patients with myeloproliferative diseases.
    Grossi A; Vannucchi AM; Rafanelli D; Filimberti E; Rossi Ferrini P
    Thromb Res; 1986 Aug; 43(3):367-74. PubMed ID: 2426823
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum lactic dehydrogenase activity and folate deficiency in myelosclerosis and other haematological diseases.
    Hoffbrand AV; Kremenchuzky S; Butterworth PJ; Mollin DL
    Br Med J; 1966 Mar; 1(5487):577-81. PubMed ID: 5217755
    [No Abstract]   [Full Text] [Related]  

  • 4. Vitamin B14-binding protein in polycythemia vera plasma.
    Hall CA; Finkler AE
    J Lab Clin Med; 1969 Jan; 73(1):60-9. PubMed ID: 5762165
    [No Abstract]   [Full Text] [Related]  

  • 5. [MYELOPROLIFERATIVE DISORDERS].
    MARCIACQ ALTAFULLA
    Arch Med Panamenos; 1963 Aug; 12():149-59. PubMed ID: 14164997
    [No Abstract]   [Full Text] [Related]  

  • 6. [MYELOPROLIFERATIVE SYNDROMES].
    PIRESWDA F
    Folha Med; 1964 Apr; 48():195-201. PubMed ID: 14271209
    [No Abstract]   [Full Text] [Related]  

  • 7. [Murine iron metabolism studies using a whole body counter method].
    Deseö G; Csaba B; Nagy G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(4):337-44. PubMed ID: 4127128
    [No Abstract]   [Full Text] [Related]  

  • 8. [Erythropoietic rate measured by ferrokinetics].
    Montz R
    Nucl Med (Stuttg); 1970 Mar; 9(1):50-61. PubMed ID: 5505733
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of beta-catenin in chronic myeloproliferative disorders.
    Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
    Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms.
    Boiocchi L; Vener C; Savi F; Bonoldi E; Moro A; Fracchiolla NS; Iurlo A; Deliliers GL; Coggi G; Bosari S; Gianelli U
    J Clin Pathol; 2011 Mar; 64(3):226-31. PubMed ID: 21217153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BLOOD CELL ANTIBODY FINDINGS IN PANCYTOPENIAS AND MYELOPROLIFERATIVE DISEASES].
    HERRMANN H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1964; 82():140-50. PubMed ID: 14234664
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship of erythromonocytic leukemia to other myeloproliferative disorders.
    Shaw MT; Bottomley SS; Bottomley RH; Hussein KK
    Am J Med; 1973 Oct; 55(3):542-8. PubMed ID: 4355172
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
    Tangün Y
    Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
    [No Abstract]   [Full Text] [Related]  

  • 14. β-catenin and PPAR-γ levels in bone marrow of myeloproliferative neoplasm: an immunohistochemical and ultrastructural study.
    Subotički T; Mitrović Ajtić O; Mićić M; Kravić Stevović T; Đikić D; Diklić M; Leković D; Gotić M; Čokić VP
    Ultrastruct Pathol; 2018; 42(6):498-507. PubMed ID: 30582392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The primary proliferative processes of the hemopoietic system].
    Introzzi P
    Minerva Med; 1969 Sep; 60(74):3399-450. PubMed ID: 4981171
    [No Abstract]   [Full Text] [Related]  

  • 16. Uric acid metabolism in proliferative diseases of the marrow.
    LYNCH EC
    Arch Intern Med; 1962 Jun; 109():639-53. PubMed ID: 14467574
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromosomal abnormalities in human neoplasia.
    Sandberg AA; Hossfeld DK
    Annu Rev Med; 1970; 21():379-408. PubMed ID: 4247449
    [No Abstract]   [Full Text] [Related]  

  • 18. [HISTIOCYTIC MULTIPLE MYELOMA WITH PARTIAL ERYTHRO-MYELOBLASTIC AND POLYKARYOCYTIC METAPLASIA AND ERYTHRO-LEUKEMIC SYNDROME].
    BENETAZZO B; GIARDINI O
    Med Clin Sper; 1964; 14():162-74. PubMed ID: 14189986
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytogenetic studies in the chronic myeloproliferative syndrome.
    Kiossoglou KA; Mitus WJ; Dameshek W
    Blood; 1966 Aug; 28(2):241-52. PubMed ID: 5222584
    [No Abstract]   [Full Text] [Related]  

  • 20. Transitions among the myeloproliferative disorders.
    Glasser RM; Walker RI
    Ann Intern Med; 1969 Aug; 71(2):285-307. PubMed ID: 5257058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.